Results 191 to 200 of about 28,490 (237)

Mucin-degrading gut bacteria: context-dependent roles in intestinal homeostasis and disease. [PDF]

Gut Microbes
Tiffany E, Kim KS, Sittipo P, Lee DW, Lee YK.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Bacteroides fragilis Group: Trends in Resistance

Current Microbiology, 2006
Representing the major part of the human colon microflora, members of the Bacteroides fragilis group are frequently involved in mixed aerobic and anaerobic infections. Recent studies show an increased resistance of the B. fragilis group against several antimicrobial agents.
Manfred, Fille, Monica, Mango, Matthias, Lechner, Reiner, Schaumann   +3 more
openaire   +2 more sources

Prevalence of the Bacteroides fragilis Group and Enterotoxigenic Bacteroides fragilis in Immunodeficient Children

Anaerobe, 2001
Members of the Bacteroides fragilis group are indigenous to the human and animal intestinal microbiota and they are responsible for several endogenous infections. Enterotoxigenic B. fragilis (ETBF) has been associated with acute diarrhea in children and farm animals.
Marcela A. Bressane, Luiz E. Durigon, Mario J. Avila-Campos   +2 more
openaire   +1 more source

Significance of encapsulated Bacteroides melaninogenicus and Bacteroides fragilis groups in mixed infections

Infection and Immunity, 1984
Organisms of the Bacteroides melaninogenicus and Bacteroides fragilis groups are often found mixed with facultatively anaerobic organisms in infections. The relative importance of these Bacteroides groups and facultative anaerobic pathogens in mixed infections was investigated in a subcutaneous abscess model in mice.
I, Brook, R I, Walker
openaire   +2 more sources

Transferable 5-Nitroimidazole resistance in the Bacteroides fragilis group

Plasmid, 1989
We report the characterization of a strain of Bacteroides vulgatus, BV17, that exhibits a moderate resistance to 5-nitroimidazoles and carries plasmids of 4.5, 5, 7.7, and 56 kb. A genetic determinant involved in this resistance is carried by the 7.7 +/- 0.2-kb plasmid (pIP417).
J, Breuil, A, Dublanchet, N, Truffaut, M, Sebald   +3 more
openaire   +2 more sources

Survey of Bacteroides fragilis group susceptibility patterns in Brazil

International Journal of Antimicrobial Agents, 1997
A total of 83 clinical isolates of the Bacteroides fragilis group collected from two Brazilian hospitals during 1993 and 1994, were tested for susceptibility to six antimicrobial agents by using an agar dilution method. The species most frequently isolated was B. fragilis (63.8%), followed by B. thetaiotaomicron (15.6%), B.
C B, Mano de Carvalho, J B, Moreira, M C, Ferreira   +2 more
openaire   +2 more sources

Antibiotic Susceptibility of Bacteroides fragilis Group Strains in Hungary

Anaerobe, 1995
Resistance rates to different antibiotics of 495 Bacteroides fragilis group strains were followed between 1987 and 1994 in Hungary. In 1992 the strains were collected in three different laboratories, whereas during the other periods strains were isolated in one centre.
E, Nagy, I, Szoke, M, Gacs, K, Csiszár
openaire   +2 more sources

Epidemiology of clindamycin resistance in the Bacteroides fragilis group

Journal of Antimicrobial Chemotherapy, 1984
A study was made of trends in the susceptibility rates to clindamycin of 338 clinical strains of the Bacteroides fragilis group isolated in the period 1980-83. In 1980, the resistance rate of the species Bact. fragilis to 4 mg/l was only 3.3%, but this percentage increased regularly in 1981 (6.2%), 1982 (15.5%) and reached 19.6% in 1983.
M, Reig, M G, Campello, F, Baquero
openaire   +2 more sources

Potential Factors Influencing Carbapenem Activity Against Bacteroides fragilis Group Isolates

Clinical Infectious Diseases, 1995
A total of 1 11 randomly collected Bacteroides fragilis group strains obtained from clinical trials of meropenem for the treatment of intraabdominal and skin or skin-structure infections were screened for their in vitro susceptibility to meropenem, imipenem, and four other broad-spectrum antimicrobial agents.
J P, Iaconis, H L, Nadler, W, Sheikh
openaire   +2 more sources